HKMPY Hikma Pharmaceuticals Plc Sponsored ADRs

Hikma Pharmaceuticals Plc engages in developing, manufacturing, and marketing branded and non-branded generic pharmaceutical products. It operates through the following segments: Branded, Injectables, Generics, and Others. The Branded segment sells branded generics and in-licensed patented products in the Middle East and North Africa. The Injectables segment includes generic injectable products distributed globally and primarily used in hospitals. The Generics segment focuses on oral and other non-injectable generic products, and is sold in the U.S. retail market. The Others segment comprises of Arab Medical Containers Ltd., International Pharmaceutical Research Center Ltd. and the chemicals division of Hikma Pharmaceuticals Ltd. (Jordan). The company was founded by Samih Taleb Darwazah in 1978 and is headquartered in London, the United Kingdom. This is an ADR of a company whose stock trades outside of the U.S. as the symbol LN:HIK.

This security is traded over-the-counter, or OTC. We don't always have accurate pricing data on OTC stocks.

$56.21    Pink
As of 01/27/2022     OTCMarkets


Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  Jordan
Country of incorporation:  United Kingdom
IPO date:  09/29/2009
Outstanding shares:  115,749,028
Average volume:  1,766
Market cap:   $6,506,251,264
Current dividend yield:  1.83%
Sedol:      
Valuation   (See tab for details)
PE ratio:   13.39
PB ratio:   2.84
PS ratio:   2.95
Return on equity:   21.22%
Net income %:   22.02%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy